Invention Grant
- Patent Title: Method of enhancing cognition in individuals with at least normal cognition
-
Application No.: US17903284Application Date: 2022-09-06
-
Publication No.: US11883457B1Publication Date: 2024-01-30
- Inventor: Daniel A Zwiren , O'neil Guthrie , Vincent C Giampapa
- Applicant: OPTIGENEX INC.
- Applicant Address: US AZ Scottsdale
- Assignee: OPTIGENEX INC.
- Current Assignee: OPTIGENEX INC.
- Current Assignee Address: US AZ Scottsdale
- Agent H. Jay Spiegel
- Main IPC: A61K36/74
- IPC: A61K36/74 ; A61P25/28 ; A61K9/00 ; A61K9/70

Abstract:
AC-11® is a federally registered trademark covering a product consisting of an aqueous extract of the botanical Uncaria tomentosa. Applicants have found that administration of AC-11® product in a pharmaceutically effective amount and for a sufficient time period results in enhancement of cognition in people with normal cognition prior to commencing administration. The method of administering the AC-11® product is disclosed and claimed.
Information query